Vein valve function after clot removal for acute deep vein thrombosis in the leg
Looks at vein valve function after AngioJet clot removal in leg thrombosis.
Key facts
- Who runs it
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Where
- China7 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Preservation of Venous Valvular Function After PMT for Acute DVT
- Status
- Enrolling by invitation
- People taking part
- 100 people, planned
- Started
- 6 Jun 2022
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- AngioJet device
- anticoagulation alone
- Record updated
- 5 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a sudden, symptom-causing blood clot in the deep veins of the leg or pelvis. It studies how well the vein valves work after clot removal with a catheter device.
- Age
- 18 Years to 80 Years
- Sex
- All sexes can join.
- Disease stage
- Acute, symptomatic deep vein thrombosis (DVT) close to the body's center. It involves the femoral, popliteal, common femoral and/or iliac veins.
- Earlier treatment
- Patients were treated with catheter-based clot removal (PCDT) using the Zelante device (Boston Scientific). One group gets anticoagulation (blood thinners) alone.
Main reasons for not taking part
- Symptoms for more than 14 days
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Patients with acute symptomatic proximal DVT involving the femoral, and/or popliteal vein, common femoral vein, iliac veins (with or without other involved ipsilateral veins) were enrolled at seven vascular centers in China. Patients were treated with PCDT via Zelante device (Boston Scientific)
Who cannot take part
- Participants were excluded if they had symptoms for more than 14 days
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.
The 2 groups in the trial
- Pharmacomechanical Catheter-directed Thrombolysis for acute DVTTreatment being tested
AngioJet, Boston Scientific
Treatment: AngioJet device
- anticoagulation alone for acute DVTPlacebo, for comparison
Treatment: anticoagulation alone
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Endovascular Thrombectomy for Femoral Popliteal Vein Thrombosis on Venous Valve Function Maintenance: a Single-center, Single-arm Prospective Observational Study
- Plain-language title
- Vein valve function after clot removal for acute deep vein thrombosis in the legGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT05588284, who can take part
- Record updated
- 5 May 2026